tion and the time of coronary angiography. That vasospasm might be responsible for ischemia and/or infarction in the absence of detectable coronary pathology has been suggested by the angiographic demonstration of spasm in association with Prinzmetal's variant angina,'-'by a report of severe precordial pain, ST segment elevations, and elevation of serum myocardial enzymes following angiographically demonstrated coronary spasm,6 and by virtue of the findings of angina, infarction, and sudden death in munitions workers following withdrawal from chronic exposure to nitroglycerin.7 In this letter we wish to present evidence suggesting that the hypothesis which implicates thrombosis or embolization need not exclude coronary vasospasm as the possible pathogenetic precursor to those episodes of myocardial ischemia or infarction which are considered to occur in the presence of "normal" coronary arteries.
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In scanning electron microscopic (SEM) studies of experimental cerebral vasospasm of the cat basilar artery (induced by mechanical stroking, stimulation by bipolar electrodes, or by introduction of autologous blood into the adjacent subarachnoid space) we routinely found endothelial desquamation, marked platelet-fibrin attachment to exposed subendothelial tissues, and subsequent thrombus formation at the point of maximum arterial constriction8 (unpublished observation). In the latter report we have presented evidence which suggests that this endothelial desquamation is a result of the increased hemodynamic shear forces associated with an acutely narrowed arterial segment. Although SEM studies of experimental coronary vasospasm (with correlative postmortem histopathological examination) are necessary for confirmation, we suggest that coronary arterial spasm may result in myocardial ischemia or infarction, not only because of its associated vascular constriction, but also as a consequence of the marked endothelial cell damage which occurs at the site of spasm. Such endothelial damage, as has been observed in our studies of cerebral vasospasm, may result in thrombus formation at the site of coronary spasm followed by partial or total arterial occlusion at that site or distally following embolization. In view of this evidence of endothelial cell damage and subsequent thrombosis, we believe that coronary vasospasm remains a most likely mechanism in the pathogenesis of myocardial infarction in the presence of "angiographically normal coronary arteries." S. DAVID GERTZ, PH.D. RICHARD Terminal ECGs
To the Editor:
We read with interest the article by Gradman et al. published in a recent issue of Circulation.' The authors' statement that "documentation of the actual mechanism of the arrhythmic death in ambulatory subjects has not appeared in the literature" is not, however, entirely correct. As a matter of fact, a few years ago we reported a similar documentation of terminal electrocardiographic events in a lady in her sixties complaining of palpitations for which she was monitored with a portable tape recorder. Serial Serum CPK Determinations to Evaluate Therapy in AMI To the Editor: Serial serum CPK determinations during the first hours after the initial elevation of enzyme activity following acute myocardial infarction (AMI) has enabled workers like W.E. Shell, B.E. Sobel and others' to compute the further development in serum CPK activity and to predict the infarct size in experimental dog studies and on patients with sudden and acute myocardial infarction.
Further observations of myocardial protection treatment starting ca 5 hours (dogs) or ca 8 hours (humans) after initial CPK elevation have revealed a rapid and drastic fall in CPK activity,'-'and it is concluded that the drop in CPK activity compared to the computed values is a result of salvage of the jeopardized zone of the infarction area, obtained by the treatment. Various kinds of treatments have been applied such as administration of propranolol (dogs) or trimetaphane (hypertensive humans), or reperfusion by release of constricting coronary cuff (dogs).
The authors later placed a limitation on their findings in that both the prediction of infarct size and the evaluation of treatment can only be performed in groups of patients and not in the individual patient. 4 However, judging from the published experimental data we have two major objections to these conclusions.
1) The drop in CPK activity after the onset of treatment is in all cases reported too rapid to be explained only by salvage of the jeopardized zone. Even if all the cells (both the jeopardized and the irreversibly damaged ones) immediately ceased to release CPK, the activity drops many times faster than can be explained from the decay rate.
2) The drop in CPK activity seems, in most of the reported
